186 related articles for article (PubMed ID: 20304345)
41. Immunization strategies for the elimination of hepatitis B.
Reece SM
Nurse Pract; 1993 Feb; 18(2):42-5, 49-50. PubMed ID: 8455811
[TBL] [Abstract][Full Text] [Related]
42. Impact of universal vaccination on intrafamilial transmission of hepatitis B virus.
Mu SC; Wang GM; Jow GM; Chen BF
J Med Virol; 2011 May; 83(5):783-90. PubMed ID: 21360549
[TBL] [Abstract][Full Text] [Related]
43. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
Nassauer KA
Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
[TBL] [Abstract][Full Text] [Related]
44. Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.
Howell J; Lemoine M; Thursz M
J Viral Hepat; 2014 Jun; 21(6):381-96. PubMed ID: 24827901
[TBL] [Abstract][Full Text] [Related]
45. [A study on serologic markers for screening before hepatitis B vaccination].
Hui Z; Zhao Z; Zhang L
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):351-3. PubMed ID: 7874705
[TBL] [Abstract][Full Text] [Related]
46. Serologic response to hepatitis B vaccination in children with isolated anti-Hbc.
Atabek ME; Erkul I
J Trop Pediatr; 2006 Feb; 52(1):71-2. PubMed ID: 15917263
[No Abstract] [Full Text] [Related]
47. Morbidity from hepatitis B after introduction of nationwide immunisation in Italy.
Squarcione S; Pompa MG; Vellucci L
Lancet; 1997 Jul; 350(9071):114. PubMed ID: 9228969
[No Abstract] [Full Text] [Related]
48. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization.
Freed GL; Freeman VA; Clark SJ; Konrad TR; Pathman DE
J Fam Pract; 1996 Jun; 42(6):587-92. PubMed ID: 8656169
[TBL] [Abstract][Full Text] [Related]
49. School-based adolescent hepatitis B vaccination.
Cassidy WM
J La State Med Soc; 1999 Dec; 151(12):622-6. PubMed ID: 10643204
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1992 Jan; 146(1):25-8. PubMed ID: 1530816
[No Abstract] [Full Text] [Related]
51. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
[TBL] [Abstract][Full Text] [Related]
52. [Hepatitis B vaccination of children and adolescents].
Jilg W
Fortschr Med; 1997 Apr; 115(10):26, 29-32, 33. PubMed ID: 9206683
[TBL] [Abstract][Full Text] [Related]
53. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
Eichhorn R
Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
[No Abstract] [Full Text] [Related]
54. [Because of its complications prevention is vital. Hepatitis B vaccination is available even for infants. Interview by Dr. Rolf Rolf-Günther Sommer].
Hallauer JF
Fortschr Med; 1997 Mar; 115(8):43-4. PubMed ID: 9173032
[No Abstract] [Full Text] [Related]
55. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
Romanò L; Biffi R; Bianchi S; Zanetti A
Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
[No Abstract] [Full Text] [Related]
56. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
Gervais A; Longuet P; Leport C
Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
[No Abstract] [Full Text] [Related]
57. [Measuring the effectiveness of hepatitis B vaccination].
Peiró S; Márquez Calderón S; Lluch JA
Med Clin (Barc); 1996 Jul; 107(6):238-9. PubMed ID: 8755454
[No Abstract] [Full Text] [Related]
58. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
[TBL] [Abstract][Full Text] [Related]
59. [Combined prevention of hepatitis A and B].
Fortschr Med; 1997 May; 115(13):18. PubMed ID: 9324474
[No Abstract] [Full Text] [Related]
60. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
